Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008–2012
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008–2012
Filetype[PDF-471.95 KB]


Details:
  • Alternative Title:
    Int J Stroke
  • Personal Author:
  • Description:
    Background Limited studies exist on the outcome of thrombolytic therapy of acute ischemic stroke patients outside of clinical trials. Aim To assess the possible risk factors associated with in-hospital death and symptomatic intracerebral hemorrhage among patients who received intravenous tissue plasminogen activator. Methods A total of 7193 patients with a clinical diagnosis of acute ischemic stroke and a documented National Institutes of Health Stroke Scale score were treated with intravenous tissue plasminogen activator within 4·5 hours of time last known to be well. Generalized estimating equations modeling was used to assess the associations of in-hospital death and symptomatic intracerebral hemorrhage with clinical characteristics. Results Among 7193 patients treated with intravenous tissue plasminogen activator, 516 (7·2%) died during hospitalization. Factors associated with in-hospital death were older age, male gender, National Institutes of Health Stroke Scale score, history of myocardial infarction or coronary artery disease, and history of nonvalvular atrial fibrillation. Increasing age, higher National Institutes of Health Stroke Scale score, and history of dyslipidemia were associated with symptomatic intracerebral hemorrhage. There was no difference in the rates of in-hospital death or symptomatic intracerebral hemorrhage among patients treated with intravenous tissue plasminogen activator within three-hours of time last known to be well and those treated between three and 4·5 hours after this time. Conclusions In this study of acute ischemic stroke patients, older age, male gender, National Institutes of Health Stroke Scale score, history of myocardial infarction or coronary artery disease, and history of atrial fibrillation were associated with increased in-hospital death among patients receiving intravenous tissue plasminogen activator. Among patients treated with intravenous tissue plasminogen activator, in-hospital mortality and symptomatic intracerebral hemorrhage rates were similar between those treated within three-hours of time last known to be well and those treated between three and 4·5 hours after this time.
  • Subject:
  • Pubmed ID:
    24024962
  • Pubmed Central ID:
    PMC4451118
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 477.21 KB]
    Personal Author:
    Asaithambi, Ganesh; Tong, Xin; George, Mary G.; Tsai, Albert W.; Peacock, James M.; Luepker, Russell V.; Lakshminarayan, Kamakshi;
    Published Date:
    Aug 23 2014
    Source:
    J Stroke Cerebrovasc Dis. 2014; 23(9):2316-2321.
    Description:
    BackgroundThe American Heart Association/American Stroke Association (AHA/ ASA) recommended an expansion of the time window for acute ischemic stroke (AIS) reperfusion with intravenous (IV) recombinant tissue plasminogen activator (rt-PA) from 3 to 4...
    File Type:
    Filetype[PDF - 477.21 KB]
  2. Filetype[PDF - 1.50 MB]
    Personal Author:
    Tong, Xin; Wiltz, Jennifer L.; George, Mary G.; Odom, Erika C.; King, Sallyann M. Coleman; Chang, Tiffany; Yin, Xiaoping; Merritt, Robert K.;
    Corporate Authors:
    Paul Coverdell National Acute Stroke Program team
    Published Date:
    Dec 2018
    Source:
    Circ Cardiovasc Qual Outcomes. 11(12):e004981
    Description:
    BACKGROUND:The clinical benefit of intravenous (IV) alteplase in acute ischemic stroke is time dependent. We assessed the overall temporal changes in door-to-needle (DTN) time and examine the factors associated with DTN time ≤60 and ≤45 minutes.M...
    File Type:
    Filetype[PDF - 1.50 MB]
  3. Filetype[PDF - 370.74 KB]
    Personal Author:
    Asaithambi, Ganesh; Tong, Xin; Lakshminarayan, Kamakshi; King, Sallyann M Coleman; George, Mary G;
    Published Date:
    October 2019
    Source:
    J Neurointerv Surg. 12(6):574-578
    Description:
    BackgroundThe intra-arterial treatment (IAT) of acute ischemic stroke (AIS) is now evidence-based and given the highest level of recommendation among eligible patients. Using a multi-state stroke registry, we studied the trend in IAT among patients w...
    File Type:
    Filetype[PDF - 370.74 KB]
  4. Filetype[PDF - 509.10 KB]
    Personal Author:
    Jain, S.; Self, W.H.; Wunderink, R.G.; Fakhran, S.; Balk, R.; Bramley, A.M.; Reed, C.; Grijalva, C.G.; Anderson, E.J.; Courtney, D.M.; Chappell, J.D.; Qi, C.; Hart, E.M.; Carroll, F.; Trabue, C.; Donnelly, H.K.; Williams, D.J.; Zhu, Y.; Arnold, S.R.; Ampofo, K.; Waterer, G.W.; Levine, M.; Lindstrom, S.; Winchell, J.M.; Katz, J.M.; Erdman, D.; Schneider, E.; Hicks, L.A.; McCullers, J.A.; Pavia, A.T.; Edwards, K.M.; Finelli, L.;
    Published Date:
    July 14 2015
    Source:
    N Engl J Med. 373(5):415-427
    Description:
    BACKGROUNDCommunity-acquired pneumonia is a leading infectious cause of hospitalization and death among U.S. adults. Incidence estimates of pneumonia confirmed radio-graphically and with the use of current laboratory diagnostic tests are needed.METHO...
    File Type:
    Filetype[PDF - 509.10 KB]
  5. Filetype[PDF - 356.17 KB]
    Personal Author:
    Kowalski, Robert G.; Haarbauer-Krupa, Juliet K.; Bell, Jeneita M.; Corrigan, John D.; Hammond, Flora M.; Torbey, Michel T.; Hofmann, Melissa C.; Dams-O’Connor, Kristen; Miller, A. Cate; Whiteneck, Gale G.;
    Published Date:
    Jun 13 2017
    Source:
    Stroke. 48(7):1802-1809.
    Description:
    Background and PurposeTraumatic brain injury (TBI) leads to nearly 300 000 annual US hospitalizations and increased lifetime risk of acute ischemic stroke (AIS). Occurrence of AIS immediately after TBI has not been well characterized. We evaluated AI...
    File Type:
    Filetype[PDF - 356.17 KB]